By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Prothena Corporation plc 

25-28 North Wall Quay

  Dublin  1  Ireland
Phone: 353-1-902-3519 Fax: 353-1-902-3510



Company News
Prothena Corporation plc Announces Pricing Of Public Offering Of 4,750,000 Ordinary Shares 6/25/2014 8:08:33 AM
Prothena Corporation plc Announces Proposed Offering Of Ordinary Shares 6/24/2014 7:45:54 AM
Prothena Corporation plc To Present At The Jefferies and Co. 2014 Global Healthcare Conference In New York 5/28/2014 9:58:32 AM
Prothena Corporation plc Reports First Quarter 2014 Financial Results And Provides R&D Updates 5/6/2014 9:24:48 AM
Prothena Corporation plc To Host Webcast And Conference Call To Discuss Interim Phase 1 Data Of Ongoing NEOD001 Study In Patients With AL Amyloidosis On May 2 5/1/2014 4:33:51 PM
Prothena Corporation plc Announces Appointment Of Chief Legal Officer 4/30/2014 3:55:47 PM
Prothena Corporation plc's NEOD001 Demonstrates Encouraging Cardiac Biomarker Responses In Ongoing Phase 1 Study In Patients With Immunoglobulin Light Chain (AL) Amyloidosis 4/23/2014 2:51:48 PM
Prothena Corporation plc Release: First Human Dosed In Phase 1 Study Of PRX002 For Treatment Of Parkinson's Disease 4/9/2014 8:55:14 AM
Prothena Corporation plc Announces Clinical Data To Be Presented At The International Symposium On Amyloidosis 3/19/2014 9:27:58 AM
Prothena Corporation plc Reports Fourth Quarter And Full Year 2013 Financial Results And Provides Research And Development Update 3/7/2014 8:43:17 AM